ALTANA Pharma (AAA) Files A Suit Against Reference Prices At The Social Court
10/19/2005 5:12:22 PM
ALTANA AG (NYSE:AAA)(FWB:ALT) announced today that at the beginning of December, ALTANA Pharma has filed a suit at the Social Court in Berlin against the central association (Spitzenverbaende) of the German statutory health insurance companies with reference to their classification of Pantozol(R) (Pantoprazole) as part of a reference price group. ALTANA Pharma is of the opinion that the therapeutical improvements of Pantozol(R), e.g. less interactions with other drugs, has not been taken into account in the establishment of reference price groups for the class of proton pump inhibitors. The suit is directed against this wrong decision as well as the missing transparency of the proceedings of the Federal Committee. Furthermore, reference prices for innovative drugs contravene the objectives of patent protection.
comments powered by